Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12181246rdf:typepubmed:Citationlld:pubmed
pubmed-article:12181246lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12181246lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:12181246lifeskim:mentionsumls-concept:C0278488lld:lifeskim
pubmed-article:12181246lifeskim:mentionsumls-concept:C0246415lld:lifeskim
pubmed-article:12181246lifeskim:mentionsumls-concept:C0050385lld:lifeskim
pubmed-article:12181246lifeskim:mentionsumls-concept:C0282460lld:lifeskim
pubmed-article:12181246lifeskim:mentionsumls-concept:C1705294lld:lifeskim
pubmed-article:12181246pubmed:issue8lld:pubmed
pubmed-article:12181246pubmed:dateCreated2002-8-15lld:pubmed
pubmed-article:12181246pubmed:abstractTextDocetaxel has yielded promising response rates as a component of doxorubicin-based combination schedules in patients with metastatic breast cancer, including docetaxel/doxorubicin and docetaxel/doxorubicin/cyclophosphamide (AC). This randomized two-stage phase II study was conducted to evaluate sequential treatment with docetaxel and AC as first-line treatment in patients with recurrent or metastatic breast cancer previously untreated with chemotherapy for metastatic disease.lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:languageenglld:pubmed
pubmed-article:12181246pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:citationSubsetIMlld:pubmed
pubmed-article:12181246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12181246pubmed:statusMEDLINElld:pubmed
pubmed-article:12181246pubmed:monthAuglld:pubmed
pubmed-article:12181246pubmed:issn0923-7534lld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:AdamsJ CJClld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:IngleJ NJNlld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:MichalakJ CJClld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:BaronA TATlld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:SumanV JVJlld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:PerezE AEAlld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:GeeraertsLLlld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:KuglerJ WJWlld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:MaihleNNlld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:HatfieldA KAKlld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:KurossS ASAlld:pubmed
pubmed-article:12181246pubmed:authorpubmed-author:LafkyJ MJMlld:pubmed
pubmed-article:12181246pubmed:issnTypePrintlld:pubmed
pubmed-article:12181246pubmed:volume13lld:pubmed
pubmed-article:12181246pubmed:ownerNLMlld:pubmed
pubmed-article:12181246pubmed:authorsCompleteYlld:pubmed
pubmed-article:12181246pubmed:pagination1225-35lld:pubmed
pubmed-article:12181246pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:meshHeadingpubmed-meshheading:12181246...lld:pubmed
pubmed-article:12181246pubmed:year2002lld:pubmed
pubmed-article:12181246pubmed:articleTitleA randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer.lld:pubmed
pubmed-article:12181246pubmed:affiliationMayo Clinic and Mayo Foundation, Rochester, MN, USA. perez.edith@mayo.edulld:pubmed
pubmed-article:12181246pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12181246pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12181246pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:12181246pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:12181246pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:12181246pubmed:publicationTypeMulticenter Studylld:pubmed
pubmed-article:12181246pubmed:publicationTypeClinical Trial, Phase IIlld:pubmed